Unbound MEDLINE

adalimumab journal articles from PubMed MEDLINE database

Unbound MEDLINE results for:RSS FEEDBookmark this site
adalimumab| Refine this search
1 - 10 of 917 journal articles in the PubMed databaseEmail to a friend    
 
Marshall JK 
Review: Azathioprine, infliximab, certolizumab, and adalimumab are effective for maintaining remission in Crohn disease. [JOURNAL ARTICLE]
ACP J Club 2008 May/June; 148(4):9.
Full Citation
Bacquet-Deschryver H, Jouen F, Quillard M, et al. 
Impact of Three Anti-TNFalpha Biologics on Existing and Emergent Autoimmunity in Rheumatoid Arthritis and Spondylarthropathy Patients. [JOURNAL ARTICLE]
J Clin Immunol 2008 Jun 28.
Abstract | Full Citation
Pierer M, Baerwald C 
[Biological therapy for the treatment of rheumatic diseases.] [JOURNAL ARTICLE]
Internist (Berl) 2008 Jun 29.
Abstract | Full Citation
Nikolaus S, Schreiber S 
[Anti-TNF biologics in the treatment of chronic inflammatory bowel disease.] [JOURNAL ARTICLE]
Internist (Berl) 2008 Jun 26.
Abstract | Full Citation
Haroon M, Bond U, Phelan M 
Sinusitis: a possible link with adalimumab. [JOURNAL ARTICLE]
Clin Rheumatol 2008 Jun 26.
Abstract | Full Citation
Doherty CB, Rosen T 
Evidence-based therapy for cutaneous sarcoidosis. [Journal Article]
Drugs 2008; 68(10):1361-83.
Abstract | Full Citation
Wu E, Chen L, Birnbaum H, et al. 
Retrospective claims data analysis of dosage adjustment patterns of TNF antagonists among patients with rheumatoid arthritis. [JOURNAL ARTICLE]
Curr Med Res Opin 2008 Jun 23.
Abstract | Full Citation
Haibel H, Rudwaleit M, Listing J, et al. 
Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two. [JOURNAL ARTICLE]
Arthritis Rheum 2008 Jun 24; 58(7):1981-1991.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Collamer AN, Guerrero KT, Henning JS, et al. 
Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: A literature review and potential mechanisms of action. [JOURNAL ARTICLE]
Arthritis Rheum 2008 Jun 24; 59(7):996-1001.
Abstract | Full Citation | Publisher Full Text | Find Related Articles 
Oberstein EM, Kromo O, Tozman EC 
Type I reaction of Hansen's disease with exposure to adalimumab: A case report. [JOURNAL ARTICLE]
Arthritis Rheum 2008 Jun 24; 59(7):1040-1043.
Full Citation | Publisher Full Text | Find Related Articles 
New Search Next Results
  
Medical References for Treo, iPhone or Blackberry!

Advertise on this site.